Oncology
Rizwan Haq, MD, PHD
Assistant Professor, Harvard Medical School
Boston, MA
Rizwan Haq, MD, PhD is a medical oncology specialist at Dana-Farber Cancer Institute and Assistant Professor at Harvard Medical School who focuses on developing targeted and immunotherapy treatments for melanoma and other cancers. His clinical expertise encompasses melanoma management, targeted therapies, and advanced immunotherapies including CAR-T cell therapy, with particular attention to understanding immune responses and biomarkers that predict treatment success. Dr. Haq's research has been
23+
Years in Practice
Credentials
Board Certifications
- Internal Medicine
- Medical Oncology
Education & Training
- University of Toronto (MD)
- Johns Hopkins Hospital, Osler Housestaff Training Program (Residency)
- Dana-Farber/Partners CancerCare, Medical Oncology (Fellowship)
Clinical Focus
Subspecialties
Medical Oncology
Conditions & Treatments
MelanomaImmunotherapy
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Experience
23+ years in practice